JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pellegrino, D.
Right arrow Articles by Carter, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pellegrino, D.
Right arrow Articles by Carter, E. A.
Journal of Nuclear Medicine Vol. 46 No. 9 1522-1530
© 2005 by Society of Nuclear Medicine


Basic Science Investigations

Inflammation and Infection: Imaging Properties of 18F-FDG–Labeled White Blood Cells Versus 18F-FDG

Daniela Pellegrino, PhD1,2, Ali A. Bonab, PhD2, Stephen C. Dragotakes, BS2, Justin T. Pitman, BS2, Giuliano Mariani, MD1 and Edward A. Carter, PhD2

1 Nuclear Medicine Division, Department of Oncology, University of Pisa Medical School, Pisa, Italy
2 Nuclear Medicine Division, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

18F-FDG and 18F-FDG–labeled white blood cells (18F-FDG–WBCs) are valuable radiopharmaceuticals for imaging focal sites of inflammation and infection. In the present study, the imaging properties of both radiotracers were compared in sterile and septic inflammation models. Methods: Groups of adult male Sprague–Dawley rats (100–120 g) were injected in the left posterior thigh muscle with saline solution (group 1: controls, n = 15), 0.100 mL of turpentine oil (group 2: sterile inflammation, n = 26), 109 viable Escherichia coli bacteria (group 3: E. coli septic inflammation, n = 29), or 108 viable Pseudomonas aeruginosa bacteria (group 4: P. aeruginosa septic inflammation, n = 25). Twenty-four hours later, the animals were divided into 2 groups: One received 18F-FDG intravenously and the other received human white blood cells (WBCs) labeled in vitro with 18F-FDG injected intravenously. Biodistribution and microPET studies were performed 1 h after radiotracer injection. One hour after injection with cell-associated or free 18F-FDG, phosphorimaging of abscess and contralateral muscle was performed in specimens collected from animals in groups 1, 2, and 3. The region of interest was selected within the abscess wall and values were converted to kBq/g using a 14C calibration standard curve. Thin-layer radiochromatography (TLRC) was performed to study the chemical forms of 18F within the WBCs. Results: Whole-body biodistribution demonstrated a significantly higher uptake ratio of 18F-FDG–WBCs compared with 18F-FDG in all sterile and septic inflammation models (t test: sterile, P = 0.048; E. coli, P = 0.040; P. aeruginosa, P = 0.037). microPET imaging confirmed the greater performance of 18F-FDG–WBCs versus 18F-FDG in the sterile inflammation model and in both E. coli and P. aeruginosa septic models. Phosphorimaging analysis showed higher 18F-FDG–WBC uptake than 18F-FDG in the sterile inflammation and P. aeruginosa septic models and similar tissue uptake in the E. coli septic model. Time course labeling and TLRC of lysed WBCs demonstrated that 18F-FDG was retained as 18F-FDG-6-phosphate inside WBCs for at least 2 h, corresponding to the time frame of analysis. Conclusion: 18F-FDG–WBCs gave better results compared with 18F-FDG in all sterile and septic inflammation models. These data suggest that 18F-FDG–WBC PET may be a useful technique for tracking focal inflammatory lesions in the body.

Key Words: 18F-FDG–labeled white blood cells • infection • inflammation • biodistribution • microPET • phosphorimaging




This article has been cited by other articles:


Home page
JNMHome page
C. J. Palestro
Radionuclide Imaging of Infection: In Search of the Grail
J. Nucl. Med., May 1, 2009; 50(5): 671 - 673.
[Full Text] [PDF]


Home page
JNMHome page
N. Dumarey, D. Egrise, D. Blocklet, B. Stallenberg, M. Remmelink, V. del Marmol, G. Van Simaeys, F. Jacobs, and S. Goldman
Imaging Infection with 18F-FDG-Labeled Leukocyte PET/CT: Initial Experience in 21 Patients
J. Nucl. Med., April 1, 2006; 47(4): 625 - 632.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.